Research Article | | Peer-Reviewed

Clinical and Etiological Characteristics and the Diagnostic Value of Laboratory Tests in Hemodialysis Patients with Infections at the Donka National Hemodialysis Center

Received: 2 October 2026     Accepted: 15 October 2026     Published: 31 October 2026
Views:       Downloads:
Abstract

Introduction: Infections are the leading causes of morbidity and mortality among hemodialysis patients, and low socioeconomic status makes their management extremely complex. The objective of this study was to determine the frequency of the identified causes of infection and to report the role of each laboratory test in the diagnosis of infections. Patients and Methods: Our descriptive, prospective study was conducted from February 1 to July 31, 2025. Included were all hemodialysis patients, regardless of the type of extracorporeal renal replacement therapy, in whom the diagnosis of infection was established based on clinical evidence (functional, general, and physical signs) and/or paraclinical evidence (biological, radiological, and morphological findings), regardless of the vascular access or site of infection. Our variables were both quantitative and qualitative and were categorized into epidemiological, clinical, and paraclinical data to determine the etiology and identify the causative microorganism. Results: Of the 386 patients, 145 (37.6%) were diagnosed with an infectious syndrome. The most common general symptoms were fever (94%) and chills (29%). Blood cultures were ordered for 98 patients; 54% underwent the test, and 39.6% of those tested positive. Stool culture (98 requests, 47.9% performed, and 36.2% positive); cytology (67 requests, 95.5% performed, and 20.3% positive); catheter tip culture (36 requests, 91.7% performed, and 66.7% positive); chest X-ray (60 requests, 80% performed, and 77.1% positive). Conclusion: Infections affect more than one-third of hemodialysis patients, particularly those on temporary dialysis, where infections are both a cause and a serious complication.

Published in International Journal of Infectious Diseases and Therapy (Volume 11, Issue 4)
DOI 10.11648/j.ijidt.20261104.11
Page(s) 52-60
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2026. Published by Science Publishing Group

Keywords

Infections, Clinical Presentation, Etiologies, Paraclinical Findings, Hemodialysis Patients, Donka

1. Introduction
Infections that occur in patients with renal failure undergoing hemodialysis require immediate therapeutic management that is aggressive enough to be effective quickly. They are the second most common complication observed in hemodialysis patients after cardiovascular complications, and are generally nosocomial or community-acquired in origin, representing the leading cause of morbidity and the second leading cause of death, most often linked to the immunosuppression caused by renal failure, as well as to multiple skin entry points, the hemodialysis unit environment—which is conducive to infection risk—and the treatments administered . In addition to intra-individual transmission, infectious agents can be transmitted from patient to patient, either directly or indirectly, via medical devices or contaminated surfaces, or through the contaminated hands of staff . Hemodialysis patients often develop infectious complications due to implanted catheters. The use of a hemodialysis catheter is associated with an eight-fold higher rate of bloodstream infections related to vascular access compared to an arteriovenous fistula (AVF). Infectious complications include bacteremia and exit-site infections, the majority of which occur in dialysis patients with central venous catheters (CVCs) . Central venous catheter infections are also associated with other complications, such as endocarditis, epidural abscess, and arthritis. Central venous catheter-related sepsis is responsible for increased morbidity and mortality. Reporting of bloodstream infections among outpatient hemodialysis patients may be compromised by methodological challenges. Patients who become symptomatic with fever or chills often present directly to the hospital rather than to the hemodialysis center . The prevalence of infection among dialysis patients is 42.4% in the United States . In France, a study of 1,455 hemodialysis patients found that the frequency of infectious episodes was 39% , with the main types of infections being pneumonia, vascular access infections, urinary tract infections, and viral hepatitis B and C.
In Brazil, Schwanke AA et al. reported in a study of 69 hemodialysis patients that the incidence of infection was 9.1%, and the risk factors were length of hospitalization and catheter insertion into the left femoral vein.
In Poland, Krzanowski M et al. conducted a study of 213 hemodialysis patients, of whom 181 had arteriovenous fistulas; 28 had permanent catheters and 4 had arteriovenous grafts. Infections were observed in 14.3% of patients with central venous catheters (CVCs), in 2.2% of patients with arteriovenous fistulas (AVFs), and in 50% of patients with arteriovenous grafts.
In Senegal, previous studies have been conducted on chronic hemodialysis patients in Dakar, where viral hepatitis B had a prevalence of 6.7% in 2000 , and nasal carriage of Staphylococcus was isolated in 52% of patients and 24.4% of staff in 2000 .
In Cameroon, Fouda H et al. found that, out of a total of 197 patients included in their study, the majority of patients (68.6%) had experienced at least one infectious complication, with catheter-related infections being the most common.
Infections are the leading causes of morbidity and mortality in our hospitals, where inadequate technical facilities and low socioeconomic status are factors that make patient care extremely complex. The objective of this study was to determine the frequency of the identified etiologies and to report the contribution of each laboratory test to the diagnosis of infections.
2. Patients and Methodes
The National Hemodialysis Center at Donka National Hospital served as the setting for this study. It is the only public hemodialysis center in the entire country. It consists of two (2) dialysis rooms staffed by a multidisciplinary team of medical, technical, and hygiene personnel.
2.1. Type and Duration of the Study
This was a descriptive, prospective study lasting 6 months, from February 1 to July 31, 2025.
2.2. Target population
Our study population consisted of hemodialysis patients during the study period.
2.3. Study Population
The study population consisted of hemodialysis patients presenting with an infection at any site who were admitted to the Donka National Hemodialysis Center.
2.4. Inclusion Criteria
Our study included all hemodialysis patients, regardless of the type of extracorporeal renal replacement therapy, in whom an infection was diagnosed based on clinical evidence (functional, general, and physical signs) and/or paraclinical evidence (laboratory, radiological, and morphological findings), regardless of the vascular access or site of infection.
2.5. Exclusion Criteria
The following were excluded:
1) Hemodialysis patients who were being treated for HIV and viral hepatitis B and/or C.
2) Patients presenting with signs of infection prior to starting dialysis.
2.6. Recruitment Method
We conducted an exhaustive recruitment of all patients meeting our inclusion criteria.
2.7. Study Variables
Our variables were both quantitative and qualitative and were categorized into epidemiological, clinical, and paraclinical data, with the aim of identifying the etiology and detecting the causative microbial agent.
Sociodemographic data: These included the patients’ sex, age, educational level, and place of residence.
Socioeconomic status: In our context, we considered the income of the person responsible for the patient’s care (the patient themselves or a close relative).
High socioeconomic status: patients with a monthly income of ≥ $700.
Medium socioeconomic status: patients with a monthly income between $300 and $700.
Low socioeconomic status: patients with a monthly income of $300 or less.
Clinical data: Clinical information was collected through patient history (functional signs, general signs, and medical history) and a comprehensive physical examination to identify sites of infection: pulmonary (pulmonary consolidation syndrome); otolaryngological (rhinorrhea, otorrhea, etc.); cutaneous (purulent discharge); cerebral (Kernig’s and Brudzinsky’s signs); and oral.
Vascular access: routes used for extracorporeal renal replacement therapy, arteriovenous fistulas, and central venous catheters (femoral, simple jugular, tunneled jugular).
Laboratory and imaging data: Laboratory tests and medical imaging studies were ordered to confirm the infectious syndrome, identify the site of infection, and isolate the causative microorganism.
Laboratory tests: blood tests (thick blood smear, blood culture); fluid samples (urine cytology, cerebrospinal fluid, pleural fluid, gastric fluid, sputum, pus); cultures (catheter tip, stool); Medical imaging: chest X-ray (pneumonia, pleurisy, pulmonary tuberculosis), cardiac Doppler ultrasound (endocarditis), abdominal ultrasound.
Type of dialysis: The extracorporeal purification technique used was hemodialysis, which was performed on patients temporarily on dialysis (acute dialysis) and patients on permanent dialysis (chronic intermittent dialysis).
Therapeutic and clinical course data: We categorized patients according to treatment class and the antibiotics used.
In terms of clinical outcome, the two categories were: a favorable outcome (improvement in clinical status) and death.
2.8. Data Collection Techniques and Instruments
To collect data, we interviewed the patients, and the data were recorded on a pre-designed questionnaire.
2.9. Statistical Analysis of the Data
Our data were collected using a pre-designed questionnaire, then analyzed using EPI INFO 7.4.0 software and presented using Microsoft Word and Excel from the Office 2016 suite.
2.10. Ethical and Professional Considerations
Informed consent was obtained from patients prior to their inclusion in the study. We respected the anonymity of all study participants.
3. Results
3.1. Epidemiological Data
During the study period, 386 patients were admitted for extracorporeal renal replacement therapy, of whom 80 were undergoing acute dialysis and 306 were undergoing chronic intermittent dialysis. Of the 386 patients, an infectious syndrome was diagnosed in 145 (37.6%), including 45 (31%) cases among patients admitted for acute dialysis and 100 (69%) among those admitted for chronic dialysis. Figure 1.
Figure 1. Distribution of hemodialysis patients by frequency of infectious syndrome at the Donka National Hemodialysis Center.
3.2. Sociodemographic Data
A predominance of males was observed (56%); patients aged 30–44 were the most affected. More than 50% had no formal education; 87% lived in urban areas; 60% had a low socioeconomic status (Table 1).
Table 1. Distribution of patients with an infectious syndrome by sociodemographic characteristics.

Variables

Sample Size (N=145)

Percentage

Gender

Male

81

56

Female

64

44

Sex-ratio = 1,26

Age (years)

<29

20

14

30 – 44

46

32

45 – 54

29

20

55 – 64

32

22

65 – 74

12

08

≥75

06

04

Average age 46,65 ± 15,33 years extremes 14 et 80 ans

Level of Education

No formal education

83

57.6

Elementary school

13

9.1

High school

18

12.1

College/University

31

21.2

Place of Origin

Rural

19

13

Urban

126

87

Socioeconomic Status

Medium

28

19.3

Low

30

20.7

Very low

87

60

3.3. Clinical Data
Pain accounted for 93% of the functional symptoms; fever and physical weakness were the predominant general symptoms, each occurring in 93.8% of patients; and 89.6% had a central venous catheter (Table 2).
Table 2. Distribution of hemodialysis patients with an infectious syndrome according to clinical signs and vascular access.

Variables

Sample Size (N=145)

Percentage

Functional Symptoms

Low back pain

135

93

Shortness of breath

130

90

Itching

125

86

Headache

123

85

Abdominal pain

110

76

Vomiting

104

72

Cough

103

71

Anuria

97

67

Burning sensation during urination

97

67

Itching

84

58

Chest pain

77

53

Vaginal discharge

52

36

Heart palpitations

46

32

Coughing up phlegm

45

31

Diarrhea

38

26

Frequent urination

42

29

General symptoms

Fever

136

94

Chills

42

29

Weakness

136

96

Loss of appetite

130

90

Weight loss

81

56

Vascular Access

Arteriovenous Fistula

15

10

Tunneled Catheter

43

30

Simple Femoral Catheter

51

35

Simple Jugular Catheter

36

25

3.4. Site of Origin of the Infection
The most commonly observed site of origin in patients was the gastrointestinal tract (67.6%; Table 3).
Table 3. Distribution of patients with an infectious syndrome by site of origin of the infection.

Entry point for the source of infection

Sample Size (N=145)

Percentage

Vascular

36

24.8

Gastrointestinal

98

67.6

Thoracic and Pulmonary

46

31.7

Cardiac

8

5.5

Cerebral

1

0.07

Urogenital

13

9

Otolaryngological

32

22.1

Oral and Dental

4

2.7

Blood

22

15.1

Skin

3

2.1

3.5. Etiological Diagnosis
Gastroenteritis was the most common cause among patients undergoing acute dialysis (46.7%) and chronic intermittent dialysis (77%), followed by urinary tract infections in the first group (13/45) and pneumonia in the second group (29/100) (Table 4).
Table 4. Distribution of patients presenting with an infectious syndrome by etiology according to the type of dialysis performed.

Etiology

Acute dialysis

Recurrent dialysis

Type of dialysis

Sample Size N=45

Percentage

Sample Size N=100

Percentage

Gastroenteritis

21

46.7

77

77

Endocarditis

-

-

8

8

Pleurisy

-

25

25

Pneumonia

11

24.4

29

29

Tunnelitis

-

-

5

5

Thrombophlebitis

-

-

7

7

Other catheter-related infections

-

-

24

24

Meningitis

1

2.2

-

-

Sinusitis

-

-

27

27

Nasopharyngitis

-

-

11

11

Urinary tract infection

13

28.9

-

-

Post-injection abscess

-

-

7

7

Dental abscess

-

-

2

2

Malaria

10

22.2

3

3

3.6. Diagnostic Tests
All patients underwent a thick smear; only 9% had a positive result. The positivity rate for chest X-rays was 77%. For blood cultures, the positivity rate was (21/53), or 39% (Table 5).
Table 5. Distribution of patients presenting with an infectious syndrome according to laboratory tests and their diagnostic value.

Tests Requested

Performed

Diagnostic Value

Blood culture (n=98)

53 (54.1%)

21 (39.6%)

Urine cytology (n=67)

64 (95.5%)

13 (20.3%)

Stool culture (n=98)

47 (47.9%)

17 (36.2%)

Catheter tip culture (n=36)

33 (91.7%)

22 (66.7%)

CSF analysis (n=1)

1 (100%)

1 (100%)

Sputum (n=52)

52 (100%)

0

Gastric intubation (n=13)

13 (100%)

0

Biological fluid analysis (n=102)

102 (100%)

63 (61.8%)

Thick smear (n=145)

145 (100%)

13 (9%)

Chest X-ray (n=60)

48 (80%)

37 (77.1%)

Cardiac ultrasound (n=52)

36 (69.2%)

8 (22.2%)

Abdominal ultrasound (n=95)

95 (100%)

11 (11.6%)

3.7. Isolated Microorganisms
The most common microorganisms found in patients undergoing acute dialysis were Streptococcus (35%) and Staphylococcus (29%). In chronic intermittent dialysis, E. coli accounted for 63% and Staphylococcus for 25% (Table 6).
Table 6. Distribution of patients according to isolated microbial pathogens based on the type of dialysis performed.

Isolated microbial pathogens

Acute dialysis (n=45)

Recurrent dialysis (n=100)

Type of dialysis

Sample Size

Percentage

Sample Size

Percentage

Klebsiella pneumonia

-

-

25

25

Streptococcus dore

16

35.5

7

7

Burkholderia cepaci

-

-

2

2

Proteus mirabilis

-

-

3

3

Staphylococcus aureus

13

28.9

19

19

Enterococcus faecalis

-

-

11

11

Plasmodium falciparum

10

22.2

3

3

Escherichia coli

6

13.3

63

63

3.8. Treatment and Clinical Course
More than 89% of our patients received two antibiotics concurrently. Third-generation ceftriaxone was the most commonly prescribed antibiotic (100%). The mortality rate was 8.3%.
Table 7. Distribution of Patients by Treatment and Clinical Course.

Number of antibiotics

Number

percentage

Monotherapy

15

10.3

Combination therapy

130

89.7

Prescribed antibiotics

Céphalosporine 3G

145

100

Amoxicilline +Acide clavulanique

55

37.9

Erythromycine 500 mg

23

15.9

Rovamycine 3M

16

11

Ciprofloxacine 500 mg

98

67.6

Gentamycine 80 mg

11

7.6

Imipénème 0,5/1g

42

29

Metronidazole perfusable 500 mg

98

67.6

Vancomycine 500 mg

10

6.9

Ofloxacine 200 mg

33

22.7

Tazobactam+Piperaciline 1/125 mg

11

7.6

Artésunate 60 mg injectable

13

9

Clinical Course

Favorable

133

91.7

Death

12

8.3

4. Discussion
4.1. Prevalence
Among the 386 hemodialysis patients, 145 had experienced at least one infectious episode during the study period, representing a prevalence of 37.5%. This rate is lower than that observed in studies conducted in France (39%) and the United States (42.4%) . This difference in prevalence may be explained by the fact that our study was single-center and had a short data collection period.
4.2. Sociodemographic Characteristics
Our patients had a mean age of 46.65 ± 15.33 years, with ages ranging from 14 to 80 years; the 30–44 age group was the most common, accounting for 32% of the total. Our results are comparable to those of AHOUI S et al. in Benin in 2019, who found in their study a mean age of 47.9 ± 4.3 years, with extremes ranging from 16 to 84 years, and in which the 30–50 age group was strongly represented. Our results differ from those of Birlutin V et al. , who found an average age of 65.47 ± 17.07 years. This difference may be related to the recruitment method, which can vary from one study to another.
Males were overrepresented in our series, accounting for 56% of the participants, with a male-to-female sex ratio of 1.27. This observation was also noted in the study by Birlutin V et al. . Nearly 58% had not attended school, 87% lived in urban areas, and 60% had a low socioeconomic status.
4.3. Clinical Signs
The most common general signs were fever (94%) and chills (29%). Low back pain (93%), dyspnea (90%), pruritus (86%), edema (85%), abdominal pain (76%), cough (71%), vomiting (72%), burning during urination, and anuria (67%) were the most common functional signs. This is consistent with the findings of Birlutin V et al., who reported fever, chills, dyspnea, cough, and cardiac, gastrointestinal, cutaneous, urinary, and neurological manifestations .
The most commonly used access site was the femoral artery, used in 35% of cases, followed by a tunneled catheter in 30% of cases.
Our data are similar to those of Tall LA et al. in Senegal in 2016, in a study on the prevalence of infections among chronic hemodialysis patients at the hemodialysis unit of the Aristide le Dantec University Hospital, who also reported that the femoral access (41%) was the most commonly used, followed by the tunneled catheter (33%) . This may be explained by the fact that most patients begin their first dialysis sessions with a femoral catheter.
4.4. Route of Entry
The site of initial infection was the gastrointestinal tract (67.6%), the pleural-pulmonary system (31.7%), and the vascular system (24.8%). The frequency of routes of entry may vary from one country to another and from one study to another. In Benin , the main sites of entry were ENT (69%) and gastrointestinal (72%). This high proportion of gastrointestinal infections is thought to be due to poor food hygiene.
4.5. Etiologies
There were 80 patients admitted for temporary dialysis due to acute kidney injury, of whom 45 presented with an infectious syndrome. Gastroenteritis was the most common cause (21/45); urinary tract infection (13/45); and pneumonia (11/45). Acute kidney injury (AKI) is a common and serious complication of pediatric sepsis, with a reported incidence ranging from approximately 25% to over 50% in critically ill children, depending on diagnostic criteria and disease severity .
Of 306 patients on chronic dialysis, 100 presented with an infectious syndrome. Among these, 77% had gastroenteritis; 29% had pneumonia; 27% had nasopharyngitis; and 24% had catheter-related cases. Our results are comparable to those of AHOUI et al. in Cotonou in 2019, who found that severe malaria (70%) was the most common cause.
4.6. Contributions of Paraclinical Tests
During this period, tests were ordered to identify the source of infection and isolate the causative pathogen. Blood cultures were ordered for 98 patients; 54% underwent the test, and 39.6% of those tested positive. Stool cultures (98 test requests, 47.9% performed, and 36.2% positive); cytology (67 requests, 95.5% performed, and 20.3% positive); catheter tip culture (36 requests, 91.7% performed, and 66.7% positive); chest X-ray (60 requests, 80% performed, and 77.1% positive). Our results differ from those of Burlitin V et al. , who found, among 30 samples (81.2% positive cases), catheter culture (4 samples, 100% positive) and stool culture (8 samples collected, 12.5% positive cases). This difference may be explained by differences in methodology, on the one hand, but also by the low socioeconomic status of our patients, which may have limited their access to testing.
4.7. Isolated Pathogens
Of the 145 diagnosed cases of infectious syndrome, microbial culture isolated the following pathogens in order of frequency: E. coli 69/145 (47.6%); Staphylococcus 32/145 (22.1%); and Streptococcus 23/145 (16%). Our results differ from those reported elsewhere , where Staphylococcus aureus accounted for 25/145 (25.5%); Klebsiella pneumoniae 19/98 (19.4%) and E. coli 15/98 (15.3%). This discrepancy may be related to a number of factors, including inadequate laboratory facilities and multidrug resistance to antibiotics.
4.8. Treatment and Course of the Disease
In our study, dual antibiotic therapy accounted for 89%, followed by ciprofloxacin (IV or tablet) and metronidazole (IV or tablet). Antibiotic prescribing depends on several factors, including the site of infection, antibiotic susceptibility, and availability. Thus, in a Romanian study , 49 out of 56, or 87.5%, received at least one antibacterial agent. Thirty-six out of forty-nine received dual antibiotic therapy. The most frequently administered antibiotic was cephalosporin (25 out of 56, or 44.6%); fluoroquinolone (17 out of 56, or 30.4%). This difference may be explained by the ease of access to this drug, its availability, and its affordability for patients of low socioeconomic status.
5. Limitations
1) The low socioeconomic status of patients in relation to the high cost of additional tests;
2) Insufficient technical resources for paraclinical investigations to identify bacterial strains;
3) The cross-sectional nature of the study, which makes it difficult to describe disease progression.
6. Conclusion
Infections affect more than one-third of hemodialysis patients, particularly those on temporary dialysis, where infections are both a cause and a serious complication. Infections originating in the gastrointestinal tract are the most common, with gastroenteritis being the primary cause. The most commonly isolated microorganism in body fluids and cultures is E. coli. Three-fifths of hemodialysis patients with low monthly incomes were unable to undergo tests for the etiological diagnosis of their infection. Authorities should intervene to ensure medical coverage for hemodialysis patients and improve the technical capabilities of the country’s bacteriology laboratories.
Abbreviations

AVF

Arteriovenous Fistula

CVC

Central Venous Catheter

HIV

Human Immunodeficiency Virus

HD

Hemodialysis

CSF

Cerebrospinal Fluid

ENT

Otolaryngology

Author Contributions
Fousseny Diakite: Conceptualization, Data curation, Formal Analysis, Methodology, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
Ibrahima Bah: Methodology, Supervision, Validation, Visualization, Writing – original draft
Soriba Bangoura: Methodology, Supervision, Validation, Visualization, Writing – review & editing
Amadou Yaya Diallo: Methodology, Supervision, Validation, Visualization
Fatoumata Kaba: Validation, Visualization
Fara Andre Sandouno: Validation, Visualization
Alseny Mariame Camara: Validation, Visualization
Mamadou Malal Diallo: Validation, Visualization
Kadiatou Mamadou Bobo Barry: Validation, Visualization
Mohamed Lamine Tegui Camara: Validation, Visualization
Damaris Yawa Leno: Validation, Visualization
Alpha Oumar Bah: Investigation
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1] Almeida BM, Moreno DH, Vasconcelos V, Cacione DG. Interventions for treating catheter‐related bloodstream infections in people receiving maintenance haemodialysis. Cochrane Database Syst Rev. 1 april 2022; 2022(4): CD013554.
[2] TRAORE O, SOUWEINE B. Expert Review: Dialysis Catheter-Related Infections in the ICU. 2008 Update from the 12th Consensus Conference on Critical Care and Emergency Medicine (Paris, 2004); available at
[3] El Marnissi S, Khomsi Z, Kassy Raymond Sylvestre A, El Harti J, Taoufik J, Chaibi A, et al. Analysis of infection risk around the patient in the hemodialysis unit at Ibn Sina Hospital in Rabat using the Failure Mode, Effects, and Criticality Analysis (FMECA) method. Nephrology & Therapeutics. March 1, 2020; 16(2): 105–17.
[4] Fisher M, Golestaneh L, Allon M, Abreo K, Mokrzycki MH. Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis. Clin J Am Soc Nephrol. 7 jan 2020; 15(1): 132-51.
[5] Schwanke AA, Danski MTR, Pontes L, Kusma SZ, Lind J. Central venous catheter for hemodialysis: incidence of infection and risk factors. Rev Bras Enferm. May 2018; 71(3).
[6] Liaño, F. Pascual, J. Gámez, C. Gallego, A. Bajo, M. A. Sicilia, L. S. and al. Acute Renal Failure Study Group. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney international, 1996, vol. 50, no 3, p. 811-818.
[7] LADEGAILLERIE G, GUESNIER M, BAUDIN F, COUREUL H, FIGARD J, GARNIER S and al. The Short Peripheral Venous Catheter. Paris Public Hospital System, 2006; 23 p. 1115 21.
[8] Golestaneh L, Mokrzycki MH. Prevention of hemodialysis catheter infections Ointments, dressings, locks, and catheter hub devices. Hemodialysis International. 2018; 22(S2): S75-82.
[9] Krzanowski M, Janda K, Chowaniec E, Sułowicz W. Hemodialysis vascular access infection and mortality in maintenance hemodialysis patients. Przegl Lek. 2011; 68(12): 1157-61.
[10] Diouf M. L, Diouf B, Niang A and al. Prevalence of Hepatitis B and C Viruses Among Patients on Chronic Hemodialysis in Dakar. Dakar Med, 2000, 45; 1, 1-4.
[11] Ka EF, Diouf B, Mbengue M, Diouf ML, Boye CS, Moreira-Diop T. Nasal carriage of Staphylococcus aureus atahemodialysis unit in Dakar. Dakar Med, 2001; 46(2): 133-137.
[12] Fouda H, Ashuntantang G, Kaze F, Halle MP. Survival in Chronic Hemodialysis in Cameroon. The Pan African Medical Journal [Internet]. 2017 [Cited June 10, 2023]; 26. Available from:
[13] Ahoui S, Vigan J, Adoukonou T. A., Dovonou C. A., Boukary Y., Alassani A. Prevalence and factors associated with kidney damage in patients with type II diabetes followed at the diabetes unit of CHUD/Borgou in 2014. Ann Univers Parakou Health Sciences. 2016; 2: 17-9.
[14] Victoria Birlutiu 1, 2, and Rares-Mircea Birlutiu 3, 4,*: Characteristics of Infections in Hemodialysis Patients: Results from a Single-Center 29-Month Observational Cohort Stud from Romania. Microorganisms 2026, 14, 230: 1-19.
[15] Jean G, Vanel T, Bresson E, Terrat JC, and al. An effective strategy to reduce the use and complications of tunneled central venous catheters in hemodialysis. Nephrol Ther 2013; 5: 280-286. In Senegal.
[16] Ait Taleb A. Infectious complications in patients on chronic hemodialysis. Medical Thesis; Casablanca, 2003; No. 362.
[17] Dieng T, Ndir O, Diallo S, Coll-Seck AM, Dieng Y. Prevalence of Cryptosporidium sp and Isospora belli in patients with acquired immunodeficiency syndrome (AIDS) in Dakar Senegal. Dakar Med. 1994; 39(2): 1214.
[18] Masson E. «Cryptosporidiose et VIH en milieu tropical» Disponible sur:
[19] Coccidiose: Diagnosis, Treatment, and Prevention. Available on:
[20] Xiao L, Fayer R, Ryan U, Upton SJ. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev. jan 2004; 17(1): 72-97.
Cite This Article
  • APA Style

    Diakite, F., Bah, I., Bangoura, S., Diallo, A. Y., Kaba, F., et al. (2026). Clinical and Etiological Characteristics and the Diagnostic Value of Laboratory Tests in Hemodialysis Patients with Infections at the Donka National Hemodialysis Center. International Journal of Infectious Diseases and Therapy, 11(4), 52-60. https://doi.org/10.11648/j.ijidt.20261104.11

    Copy | Download

    ACS Style

    Diakite, F.; Bah, I.; Bangoura, S.; Diallo, A. Y.; Kaba, F., et al. Clinical and Etiological Characteristics and the Diagnostic Value of Laboratory Tests in Hemodialysis Patients with Infections at the Donka National Hemodialysis Center. Int. J. Infect. Dis. Ther. 2026, 11(4), 52-60. doi: 10.11648/j.ijidt.20261104.11

    Copy | Download

    AMA Style

    Diakite F, Bah I, Bangoura S, Diallo AY, Kaba F, et al. Clinical and Etiological Characteristics and the Diagnostic Value of Laboratory Tests in Hemodialysis Patients with Infections at the Donka National Hemodialysis Center. Int J Infect Dis Ther. 2026;11(4):52-60. doi: 10.11648/j.ijidt.20261104.11

    Copy | Download

  • @article{10.11648/j.ijidt.20261104.11,
      author = {Fousseny Diakite and Ibrahima Bah and Soriba Bangoura and Amadou Yaya Diallo and Fatoumata Kaba and Fara Andre Sandouno and Alseny Mariame Camara and Mamadou Malal Diallo and Kadiatou Mamadou Bobo Barry and Aly Traore and Mohamed Lamine Tegui Camara and Damaris Yawa Leno and M'ballou Fatoumata Bangoura and Alpha Oumar Bah},
      title = {Clinical and Etiological Characteristics and the Diagnostic Value of Laboratory Tests in Hemodialysis Patients with Infections at the Donka National Hemodialysis Center},
      journal = {International Journal of Infectious Diseases and Therapy},
      volume = {11},
      number = {4},
      pages = {52-60},
      doi = {10.11648/j.ijidt.20261104.11},
      url = {https://doi.org/10.11648/j.ijidt.20261104.11},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijidt.20261104.11},
      abstract = {Introduction: Infections are the leading causes of morbidity and mortality among hemodialysis patients, and low socioeconomic status makes their management extremely complex. The objective of this study was to determine the frequency of the identified causes of infection and to report the role of each laboratory test in the diagnosis of infections. Patients and Methods: Our descriptive, prospective study was conducted from February 1 to July 31, 2025. Included were all hemodialysis patients, regardless of the type of extracorporeal renal replacement therapy, in whom the diagnosis of infection was established based on clinical evidence (functional, general, and physical signs) and/or paraclinical evidence (biological, radiological, and morphological findings), regardless of the vascular access or site of infection. Our variables were both quantitative and qualitative and were categorized into epidemiological, clinical, and paraclinical data to determine the etiology and identify the causative microorganism. Results: Of the 386 patients, 145 (37.6%) were diagnosed with an infectious syndrome. The most common general symptoms were fever (94%) and chills (29%). Blood cultures were ordered for 98 patients; 54% underwent the test, and 39.6% of those tested positive. Stool culture (98 requests, 47.9% performed, and 36.2% positive); cytology (67 requests, 95.5% performed, and 20.3% positive); catheter tip culture (36 requests, 91.7% performed, and 66.7% positive); chest X-ray (60 requests, 80% performed, and 77.1% positive). Conclusion: Infections affect more than one-third of hemodialysis patients, particularly those on temporary dialysis, where infections are both a cause and a serious complication.},
     year = {2026}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Clinical and Etiological Characteristics and the Diagnostic Value of Laboratory Tests in Hemodialysis Patients with Infections at the Donka National Hemodialysis Center
    AU  - Fousseny Diakite
    AU  - Ibrahima Bah
    AU  - Soriba Bangoura
    AU  - Amadou Yaya Diallo
    AU  - Fatoumata Kaba
    AU  - Fara Andre Sandouno
    AU  - Alseny Mariame Camara
    AU  - Mamadou Malal Diallo
    AU  - Kadiatou Mamadou Bobo Barry
    AU  - Aly Traore
    AU  - Mohamed Lamine Tegui Camara
    AU  - Damaris Yawa Leno
    AU  - M'ballou Fatoumata Bangoura
    AU  - Alpha Oumar Bah
    Y1  - 2026/10/31
    PY  - 2026
    N1  - https://doi.org/10.11648/j.ijidt.20261104.11
    DO  - 10.11648/j.ijidt.20261104.11
    T2  - International Journal of Infectious Diseases and Therapy
    JF  - International Journal of Infectious Diseases and Therapy
    JO  - International Journal of Infectious Diseases and Therapy
    SP  - 52
    EP  - 60
    PB  - Science Publishing Group
    SN  - 2578-966X
    UR  - https://doi.org/10.11648/j.ijidt.20261104.11
    AB  - Introduction: Infections are the leading causes of morbidity and mortality among hemodialysis patients, and low socioeconomic status makes their management extremely complex. The objective of this study was to determine the frequency of the identified causes of infection and to report the role of each laboratory test in the diagnosis of infections. Patients and Methods: Our descriptive, prospective study was conducted from February 1 to July 31, 2025. Included were all hemodialysis patients, regardless of the type of extracorporeal renal replacement therapy, in whom the diagnosis of infection was established based on clinical evidence (functional, general, and physical signs) and/or paraclinical evidence (biological, radiological, and morphological findings), regardless of the vascular access or site of infection. Our variables were both quantitative and qualitative and were categorized into epidemiological, clinical, and paraclinical data to determine the etiology and identify the causative microorganism. Results: Of the 386 patients, 145 (37.6%) were diagnosed with an infectious syndrome. The most common general symptoms were fever (94%) and chills (29%). Blood cultures were ordered for 98 patients; 54% underwent the test, and 39.6% of those tested positive. Stool culture (98 requests, 47.9% performed, and 36.2% positive); cytology (67 requests, 95.5% performed, and 20.3% positive); catheter tip culture (36 requests, 91.7% performed, and 66.7% positive); chest X-ray (60 requests, 80% performed, and 77.1% positive). Conclusion: Infections affect more than one-third of hemodialysis patients, particularly those on temporary dialysis, where infections are both a cause and a serious complication.
    VL  - 11
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Faculty of Health Sciences and Technology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Faculty of Health Sciences and Technology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; Department of Infectious and Tropical Diseases, Donka University Hospital, Conakry, Guinea

  • Faculty of Health Sciences and Technology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Faculty of Health Sciences and Technology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Faculty of Health Sciences and Technology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Faculty of Health Sciences and Technology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Faculty of Health Sciences and Technology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Faculty of Health Sciences and Technology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea; Nephrology and Hemodialysis Department, Donka University Hospital, Conakry, Guinea

  • Abstract
  • Keywords
  • Document Sections

    1. 1. Introduction
    2. 2. Patients and Methodes
    3. 3. Results
    4. 4. Discussion
    5. 5. Limitations
    6. 6. Conclusion
    Show Full Outline
  • Abbreviations
  • Author Contributions
  • Conflicts of Interest
  • References
  • Cite This Article
  • Author Information